NATtrol Adds New Streptococcal Molecular Quality Controls to Its CE/IVD Products

The NATtrol GBS Positive Control (MDZ053) and NATtrol GBS Negative Control (MDZ054) models utilize patented NATtrol™ inactivation treatment for GBS CE/IVD molecular quality controls. The units enable laboratories to verify test performance, track and monitor daily test variation, lot-to-lot test kit performance and individual operator performance.This story is related to the following:Medical Equipment Controls

Source: Industrial Newsroom - Health, Medical and Dental Supplies - August 1, 2018 Category: Medical Devices Source Type: news